2.2  0.14 (6.8%)		10-12 16:00
Open: 2.06 High: 2.28 Volume: 25,131		Pre. Close: 2.06 Low: 2 Market Cap: 17(M)

Short term
Mid term
Targets	6-month :	2.69	1-year :	3.15
Resists	First :	2.3	Second :	2.69
Pivot price	2.01
Supports	First :	2.01	Second :	1.84
MAs	MA(5) :	2.09	MA(20) :	2
	MA(100) :	2.27	MA(250) :	3.07
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	68.7	D(3) :	67.5
RSI	RSI(14): 55.2
52-week	High :	8.47	Low :	1.52

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ZJYL ] has closed It is unclear right now based on current values. 63.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.28 - 2.29	2.29 - 2.3
Low:	1.98 - 1.99	1.99 - 2
Close:	2.18 - 2.2	2.2 - 2.22

Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

Fri, 25 Sep 2026
After 79.8 million new shares, Jin Medical (ZJYL) CEO falls below 5% ownership but retains voting control. - Stock Titan

Thu, 24 Sep 2026
More than 71 million shares were issued as Jin Medical (ZJYL) closed a deal with one transfer still pending. - Stock Titan

Tue, 08 Sep 2026
Jin Medical (Nasdaq: ZJYL) to issue new shares for ginseng assets with no established business - Stock Titan

Wed, 12 Aug 2026
Jin Medical International's (NASDAQ:ZJYL) Sluggish Earnings Might Be Just The Beginning Of Its Problems - Simply Wall Street

Mon, 10 Aug 2026
ZJYL Stock Jumps Over 28% After First-Half Results - StocksToTrade

Mon, 10 Aug 2026
ZJYL Stock Jumps Over 28% On First-Half Results - Timothy Sykes

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	74 (M)
Shares Float	65 (M)
Held by Insiders	11.9 (%)
Held by Institutions	0 (%)
Shares Short	70 (K)
Shares Short P.Month	62 (K)

EPS	0.18
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.86
Profit Margin	5.9 %
Operating Margin	-7.3 %
Return on Assets (ttm)	0.5 %
Return on Equity (ttm)	4 %
Qtrly Rev. Growth	-9.7 %
Gross Profit (p.s.)	0.08
Sales Per Share	0.26
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	-7 (M)

PE Ratio	11.57
PEG Ratio	0
Price to Book value	0.56
Price to Sales	8.21
Price to Cash Flow	-273.34

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.